| Ashley Marie Dibardino, CRNA | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Ashley Marie Dibardino |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003694704 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 4704278379 (Michigan) | Primary |
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
Amgen today announced the publication of results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy), a large, randomized, double-blind, placebo-controlled, Phase 3 pivotal study of patients with chronic kidney disease (CKD) not on dialysis, moderate anemia and type-2 diabetes.
In 2004 the current Ukrainian president, Viktor Yushchenko, suffered a severe case of dioxin poisoning. In order to understand how the human body reacts to remove the poison, Empa researchers have analyzed over a hundred samples taken from the politician.
Dr. Gang Zheng and a team of biomedical researchers have discovered a "smart" organic, biodegradable nanoparticle that uses heat and light in a controlled manner to potentially target and ablate tumours with greater precision.
Findings from Boston University School of Medicine, which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes.
› Verified 1 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528010428 PECOS PAC ID: 3779496856 Enrollment ID: O20031121000336 |
News Archive
Amgen today announced the publication of results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy), a large, randomized, double-blind, placebo-controlled, Phase 3 pivotal study of patients with chronic kidney disease (CKD) not on dialysis, moderate anemia and type-2 diabetes.
In 2004 the current Ukrainian president, Viktor Yushchenko, suffered a severe case of dioxin poisoning. In order to understand how the human body reacts to remove the poison, Empa researchers have analyzed over a hundred samples taken from the politician.
Dr. Gang Zheng and a team of biomedical researchers have discovered a "smart" organic, biodegradable nanoparticle that uses heat and light in a controlled manner to potentially target and ablate tumours with greater precision.
Findings from Boston University School of Medicine, which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Marie Dibardino, CRNA 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Ashley Marie Dibardino, CRNA 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
Amgen today announced the publication of results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy), a large, randomized, double-blind, placebo-controlled, Phase 3 pivotal study of patients with chronic kidney disease (CKD) not on dialysis, moderate anemia and type-2 diabetes.
In 2004 the current Ukrainian president, Viktor Yushchenko, suffered a severe case of dioxin poisoning. In order to understand how the human body reacts to remove the poison, Empa researchers have analyzed over a hundred samples taken from the politician.
Dr. Gang Zheng and a team of biomedical researchers have discovered a "smart" organic, biodegradable nanoparticle that uses heat and light in a controlled manner to potentially target and ablate tumours with greater precision.
Findings from Boston University School of Medicine, which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes.
› Verified 1 days ago
Denise Lynn Berry, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Terrance Solan, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Paula K Globerson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Lawrence R Stump, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Mary Catherine Downey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Renee Ann Shea, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Drive, 1h247 University Hospital, Ann Arbor, MI 48109 Phone: 734-936-4280 |